| Disease | incontinentia pigmenti |
| Comorbidity | C0022116|ischemia |
| Sentences | 1 |
| PubMedID- 25313552 | Intravitreal bevacizumab as an adjunct therapy in incontinentia pigmenti with macular ischemia could be beneficial. |
Page: 1